Intellipharmaceutics Announces First Quarter 2013 Results
April 03, 2013 17:30 ET
|
Intellipharmaceutics International Inc.
TORONTO, April 3, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units
March 25, 2013 14:52 ET
|
Intellipharmaceutics International Inc.
TORONTO, March 25, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics to Raise US$3.1 Million
March 19, 2013 09:07 ET
|
Intellipharmaceutics International Inc.
TORONTO, March 19, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)
March 13, 2013 18:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, March 13, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces 2012 Year End Results
January 31, 2013 21:52 ET
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 31, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Closes US$1.5 Million Convertible Debenture Financing
January 10, 2013 17:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 10, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces Proposed Convertible Debenture Financing
January 07, 2013 08:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
Intellipharmaceutics Announces Results of Initial Phase I Clinical Trial of Controlled-Release Pregabalin and Product Updates
November 27, 2012 07:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Nov. 27, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics to Present at the 24th Annual Piper Jaffray Healthcare Conference
November 21, 2012 07:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Nov. 21, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces Third Quarter 2012 Results
October 02, 2012 17:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...